Posted by Jessica Moore on May 13th, 2024
Piper Sandler reiterated their neutral rating on shares of STERIS (NYSE:STE – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $225.00 price objective on the medical...
More of this article »